Trial Profile
Efficacy of eptifibatide in post-myocardial infarction patients with ongoing ischemic pain who refused for intervention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary) ; Ischaemic heart disorder therapies
- Indications Angina pectoris; Myocardial infarction
- Focus Therapeutic Use
- Acronyms AJMER
- 24 Sep 2014 New trial record